funded by


Scientific Management


Executive Management

Results

86 results:
  •  
    June 2025 published in “Biotech in Bavaria, Report 2024|25”: DigiMed Bayern - Achievements and future development Original Article: here January 15, 2025 published in PHARMA FAKTEN: Digitale Medizin: Kleine Schritte, konkrete Ziele „DigiMed Bayern“ – so lautet der Name eines medizinischen Pilotprojektes, das 2018 startete und im vergangenen November zu Ende ging. Welchen Nutzen…  
  •  
    DigiMed Bayern for the Medicine of the Future P4 medicine (predictive, preventive, personalized, participatory) is one of the world's most promising developments for improved, holistic and efficient healthcare. DigiMed Bayern's goal is to guide Bavaria with a flagship project into this medicine of the future. The flagship P4-medicine project DigiMed Bayern is funded by the Bavarian…  
  •  
    Over the past six years (2018–2024, Phase 1), DigiMed Bayern has made a significant contribution to the development of advanced, data-driven cardiovascular care.   In DigiMed Bayern Phase 1, valuable insights into disease-relevant mechanisms were gained, and the groundwork was laid for the development of biomarkers and therapeutic approaches. In addition, a comprehensive dataset was…  
  •  
    DigiMed Bayern for the Medicine of the Future P4 medicine (predictive, preventive, personalized, participatory) is one of the world's most promising developments for improved, holistic and efficient healthcare. DigiMed Bayern's goal is to guide Bavaria with a flagship project into this medicine of the future.  
  •  
    28.09.2022, Bayerisches Staatsministerium für Gesundheit und Pflege Holetschek zieht zum Weltherztag positive Bilanz zur Präventions-Kampagne „Hand aufs Herz“ – Verhalten kann individuelles Herzinfarktrisiko deutlich senken 12.09.2022, BioM Biotech Cluster Development GmbH Die Digitalisierung der Medizin schreitet voran: Holetschek verlängert Leuchtturmprojekt „DigiMed Bayern - für die…  
  •  
    Personalized Medicine, Prevention, and Digital Innovation WP1.1 – Cohorts & IT Infrastructure for Personalized Medicine Achievements:  Establishment of a digital platform for analyzing individual patient profiles. Development of a clinical data integration center (DIZ) compliant with the MII standard. Integration of clinical parameters, omics analyses, and imaging data. Validation…  
  •  
    DigiMed Bayern for the Medicine of the Future P4 medicine (predictive, preventive, personalized, participatory) is one of the world's most promising developments for improved, holistic and efficient healthcare. DigiMed Bayern's goal is to guide Bavaria with a flagship project into this medicine of the future.  
  •  
    P4 Medicine for Carotid Stenosis and Stroke Overview Work Package 2 is dedicated to investigating the molecular mechanisms of atherosclerosis and stroke, with a focus on the destabilization of plaques in the carotid artery and its clinical relevance. Key Findings Innovative sequencing methods: Using state-of-the-art transcriptome and proteome technologies, previously unknown genes and…  
  •  
    The KORA Cohort and Cardiovascular Research in the General Population of Bavaria Overview Work Package 4 focuses on the KORA cohort, one of the most comprehensive long-term studies on the prediction of cardiovascular disease in Bavaria. The goal is to improve risk prediction, prevention, and care through the integration of innovative OMICS data and digital infrastructure. Key Findings …  
  •  
    Multi-Omics: Genomics, Transcriptomics, Proteomics, and Metabolomics for Personalized Medicine Overview Work Package 5 is at the heart of molecular analytics in the DigiMed project and encompasses the development, implementation, and integration of state-of-the-art OMICS technologies (genomics, transcriptomics, proteomics, metabolomics) for cardiovascular research. Key Results …  
Search results 1 until 20 of 86